A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare.
Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly.
New episodes are released every Thursday.
Why is stopping something in medicine so much harder than starting something new?
How do you tell an equity story when the exit doesn’t exist yet?
And what goes into deliberately building a career towards leadership so that every role is a stepping stone?
Today we’re speaking with Torbjørn Furuseth, CEO of DoMore Diagnostics based in Oslo, Norway. DoMore Diagnostics is personalising cancer treatment by analysing tumour tissue with AI algorithms.
Of course, we’ll talk more about the science at the end of the episode.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Chapters
1:12 - From Medicine to Leadership
2:52 - Natural Leadership Instincts
5:22 - Deliberate Career Planning
7:20 - Founding a Diagnostics Company
9:12 - Building High-Performing Teams
11:47 - Shared Startup Challenges
16:12 - Articulating the Equity Story
17:32 - Lessons from Downsizing
24:18 - AI in Cancer Diagnostics
16 Sept 2026
Christian Kersten, AKIGAI
What does it take to found a biotech when you were never trained for that job?
How do you lead with confidence when imposter syndrome stands in the way?
And why does hearing someone else describe problems like yours make them seem smaller?
Today we’re speaking with Christian Kersten, CEO of AKIGAI based in Oslo, Norway, working on treatments for neuropathic pain.
We’ll talk more about the science later in the episode.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Chapters
1:06 - From doctor to founder
5:00 - The first breakthrough
9:54 - Understanding the pain
13:50 - Navigating new
31:45 - Creative freedom territory
17:00 - Facing imposter syndrome
21:12 - Shared CEO challenges
27:23 – When treatments fail patients
31:45 - Creative freedom
9 Sept 2026
Mihriban Tuna, Immutrin
Why does a little pause make a big impact?
How do you keep showing up when the hundredth investor says no?
And what does it mean to be a CEO when there’s no team yet – and every job title belongs to you?
Today we’re speaking with Mihriban Tuna, CEO of Immutrin based in Cambridge UK, a company developing best-in-class antibody-based therapy for depleting cardiac amyloid in ATTR amyloidosis.
We’ll talk more about the science at the end of the episode.
About LifeScience ORG
It’s no secret that Europe is a global leader in generating translational science. We’re grateful at LifeScience ORG to have a community of over 400 life science CEOs – leaders driving change in biotech, medtech, techBio and healthcare.
The conversations inside our community – stories of conviction, navigating challenges, and making bold decisions – inspire us every week. To hear the stories, lessons, and experiences of our life science leaders, listen to A Call to Lead @ LifeScience ORG, available on all good podcasting platforms.
Chapters
1:08 - From Scientist to CEO
3:48 - Learning Through Failure
5:58 - The Call to Step Up
9:40 - Leading Through Crisis
12:03 - The Fundraising Crucible
19:13 - Building the Right Team
23:50 - Keeping Perspective Under Pressure
30:18 - Tackling Cardiac Amyloidosis
37:18 - The Unsung Heroes of Leadership
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
1 ratings
Spotify
5.0 / 5
7 ratings
Contact A Call to Lead @LifeScience ORG
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of A Call to Lead @LifeScience ORG?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
